PGEN
#2055
Precigen, Inc. - Common Stock
5.0 5 USD
-0.01%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-0.97%
Variación mensual
+4.99%
Variación en los últimos 6 meses
+17.17%
Cambio anual
+171.51%
Cierres anteriores
5.1 2
Open
5.1 3
Mínimo
5.0 1
High
5.1 3
Volumen
329
Financials
- Market Capitalization 1.8 B
- Employee 47
- Founded 1998
- CEO Helen Sabzevari
- Website www.precigen.com
- Headquarter Virginia, United States
- FIGI BBG000QL8VH9
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2040 |  NTLA Intellia Therapeutics, Inc. - Common Stock | 13.30 USD | +2.15% | -20.88% | -9.95% | -3.06% | 1.86 B USD | ||
| 2046 |  BCAX Bicara Therapeutics Inc. - Common Stock | 28.10 USD | -0.18% | -6.05% | +30.58% | +94.60% | 1.85 B USD | ||
| 2058 |  ANAB AnaptysBio, Inc. - Common Stock | 62.51 USD | -10.46% | -6.55% | +4.18% | +77.59% | 1.82 B USD | ||
| 2059 |  ZBIO Zenas BioPharma, Inc. - Common Stock | 28.78 USD | +3.23% | +5.19% | +53.41% | +8.77% | 1.82 B USD |